Pharmacokinetic and dynamic aspects of alpha-adrenoceptor blockade in hypertension.
D000317:Adrenergic alpha-Antagonists / Q000378:metabolism* / Q000627:therapeutic use; D000818:Animals; D001682:Biological Availability; D001798:Blood Proteins / Q000378:metabolism; D001921:Brain / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D007700:Kinetics; D010643:Phenoxybenzamine / Q000378:metabolism; D010646:Phentolamine / Q000378:metabolism; D011224:Prazosin / Q000378:metabolism / Q000494:pharmacology; D011485:Protein Binding; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology
D000317:Adrenergic alpha-Antagonists; D001798:Blood Proteins; D010643:Phenoxybenzamine; D011224:Prazosin; D010646:Phentolamine